bendamustine hydrochloride
Pharmaranks rates Bendamustine Hydrochloride 3.0/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Bendamustine Hydrochloride is an alkylating drug used to treat Lymphoid Leukemia, Non-Hodgkin Lymphoma.
Alkylating Drug · by Glenmark Pharms Ltd
Generic of Vivimusta
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Bendamustine Hydrochloride
- Drug class
- Alkylating Drug
- Form
- Injectable, Powder
- Strength
- Bendamustine Hydrochloride 100MG/VIAL · Bendamustine Hydrochloride 25MG/VIAL
- Type
- Prescription (Rx)
- Brand or generic
- Generic
- May treat
- lymphoid leukemia, non-hodgkin lymphoma
- Manufacturer
- Glenmark Pharms Ltd
- FDA application
- ANDA204771
- Availability
- Discontinued (per FDA)
Drug class
How this class works, per Cyclophosphamide — StatPearls, NCBI Bookshelf (NIH).
May treat (source: NIH RxClass)
See how Bendamustine Hydrochloride ranks — best-rated alkylating drug for:
Dosage forms
Injectable and Powder
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Bendamustine Hydrochloride treat?
- Bendamustine Hydrochloride (Bendamustine Hydrochloride) may be used to treat lymphoid leukemia, non-hodgkin lymphoma, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How does Bendamustine Hydrochloride work?
- Bendamustine Hydrochloride is a alkylating drug. Alkylating chemotherapy drugs attach chemical groups to a cell's DNA, forming cross-links that lock the two DNA strands together. This damage stops the cell from copying its DNA and dividing, which triggers it to die; because they are not limited to one phase of the cell cycle, they can act on cells whether or not they are actively dividing.
- How is Bendamustine Hydrochloride rated?
- pharmaranks gives Bendamustine Hydrochloride a composite score of 3.0 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Bendamustine Hydrochloride?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Bendamustine Hydrochloride. To pay less, Bendamustine Hydrochloride is already a generic — usually the lowest-cost version — so the main levers are comparing cash prices between pharmacies and using a pharmacy discount-card service. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Bendamustine Hydrochloride?
- Bendamustine Hydrochloride is marketed by Glenmark Pharms Ltd. You can see Glenmark Pharms Ltd's full profile, rating, and other products on pharmaranks.
- Is Bendamustine Hydrochloride a brand-name or generic drug?
- Bendamustine Hydrochloride is a generic medication; its active ingredient is Bendamustine Hydrochloride. Generics contain the same active ingredient as the brand-name original and are usually lower cost.
- Is Bendamustine Hydrochloride available over the counter?
- No. Bendamustine Hydrochloride is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Bendamustine Hydrochloride come in?
- Bendamustine Hydrochloride is currently marketed as injectable and powder, per the FDA's National Drug Code Directory.
- What class of drug is Bendamustine Hydrochloride?
- Bendamustine Hydrochloride is classified as alkylating drug, per the FDA's Established Pharmacologic Class.
- Is Bendamustine Hydrochloride FDA-registered?
- Bendamustine Hydrochloride is on record with the U.S. FDA under application number ANDA204771. You can verify this on its official FDA label.
- Has Bendamustine Hydrochloride been recalled by the FDA?
- Bendamustine Hydrochloride has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Bendamustine Hydrochloride safe?
- There's no single safe-or-not verdict. pharmaranks gives Bendamustine Hydrochloride a recall-safety score of 60/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about Bendamustine Hydrochloride
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 8,330 reports naming Bendamustine Hydrochloride, and the FDA flagged 96% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- pyrexia580 reports
- covid-19408 reports
- febrile neutropenia385 reports
- neutropenia374 reports
- malignant neoplasm progression369 reports
- pneumonia360 reports
- neutrophil count decreased356 reports
- platelet count decreased346 reports
Read these as a signal, not a rate. A report does not mean Bendamustine Hydrochloride caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
gleostine
Lomustine
gliadel
Carmustine
vivimusta
Bendamustine Hydrochloride
bendeka
Bendamustine Hydrochloride
evdi
Trabectedin
ivra
Melphalan Hydrochloride
Compare Bendamustine Hydrochloride head-to-head
More alkylating drug drugs
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
bendamustine hydrochloride
60/100